These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
245 related articles for article (PubMed ID: 22136295)
1. Activated T cells modulate immunosuppression by embryonic-and bone marrow-derived mesenchymal stromal cells through a feedback mechanism. Lin W; Oh SK; Choo AB; George AJ Cytotherapy; 2012 Mar; 14(3):274-84. PubMed ID: 22136295 [TBL] [Abstract][Full Text] [Related]
2. Xenotransplantation of interferon-gamma-pretreated clumps of a human mesenchymal stem cell/extracellular matrix complex induces mouse calvarial bone regeneration. Takeshita K; Motoike S; Kajiya M; Komatsu N; Takewaki M; Ouhara K; Iwata T; Takeda K; Mizuno N; Fujita T; Kurihara H Stem Cell Res Ther; 2017 Apr; 8(1):101. PubMed ID: 28446226 [TBL] [Abstract][Full Text] [Related]
3. Adult human fibroblasts are potent immunoregulatory cells and functionally equivalent to mesenchymal stem cells. Haniffa MA; Wang XN; Holtick U; Rae M; Isaacs JD; Dickinson AM; Hilkens CM; Collin MP J Immunol; 2007 Aug; 179(3):1595-604. PubMed ID: 17641026 [TBL] [Abstract][Full Text] [Related]
4. Enhanced Immunosuppression of T Cells by Sustained Presentation of Bioactive Interferon-γ Within Three-Dimensional Mesenchymal Stem Cell Constructs. Zimmermann JA; Hettiaratchi MH; McDevitt TC Stem Cells Transl Med; 2017 Jan; 6(1):223-237. PubMed ID: 28170190 [TBL] [Abstract][Full Text] [Related]
5. Human mesenchymal stromal cells transiently increase cytokine production by activated T cells before suppressing T-cell proliferation: effect of interferon-γ and tumor necrosis factor-α stimulation. Cuerquis J; Romieu-Mourez R; François M; Routy JP; Young YK; Zhao J; Eliopoulos N Cytotherapy; 2014 Feb; 16(2):191-202. PubMed ID: 24438900 [TBL] [Abstract][Full Text] [Related]
6. Human embryonic stem cell-derived mesenchymal stromal cells ameliorate collagen-induced arthritis by inducing host-derived indoleamine 2,3 dioxygenase. Gonzalo-Gil E; Pérez-Lorenzo MJ; Galindo M; Díaz de la Guardia R; López-Millán B; Bueno C; Menéndez P; Pablos JL; Criado G Arthritis Res Ther; 2016 Apr; 18():77. PubMed ID: 27036118 [TBL] [Abstract][Full Text] [Related]
7. Bone marrow mesenchymal stromal cells (BM-MSCs) from healthy donors and auto-immune disease patients reduce the proliferation of autologous- and allogeneic-stimulated lymphocytes in vitro. Bocelli-Tyndall C; Bracci L; Spagnoli G; Braccini A; Bouchenaki M; Ceredig R; Pistoia V; Martin I; Tyndall A Rheumatology (Oxford); 2007 Mar; 46(3):403-8. PubMed ID: 16920750 [TBL] [Abstract][Full Text] [Related]
8. Quantitative activation suppression assay to evaluate human bone marrow-derived mesenchymal stromal cell potency. Salem B; Miner S; Hensel NF; Battiwalla M; Keyvanfar K; Stroncek DF; Gee AP; Hanley PJ; Bollard CM; Ito S; Barrett AJ Cytotherapy; 2015 Dec; 17(12):1675-86. PubMed ID: 26422657 [TBL] [Abstract][Full Text] [Related]
9. Human Adipose Tissue-Derived Stromal Cells Suppress Human, but Not Murine Lymphocyte Proliferation, via Indoleamine 2,3-Dioxygenase Activity. Torres Crigna A; Uhlig S; Elvers-Hornung S; Klüter H; Bieback K Cells; 2020 Nov; 9(11):. PubMed ID: 33167329 [TBL] [Abstract][Full Text] [Related]
10. Human foreskin fibroblasts exert immunomodulatory properties by a different mechanism to bone marrow stromal/stem cells. Wada N; Bartold PM; Gronthos S Stem Cells Dev; 2011 Apr; 20(4):647-59. PubMed ID: 20712449 [TBL] [Abstract][Full Text] [Related]
11. DSP30 enhances the immunosuppressive properties of mesenchymal stromal cells and protects their suppressive potential from lipopolysaccharide effects: A potential role of adenosine. Sangiorgi B; De Freitas HT; Schiavinato JL; Leão V; Haddad R; Orellana MD; Faça VM; Ferreira GA; Covas DT; Zago MA; Panepucci RA Cytotherapy; 2016 Jul; 18(7):846-59. PubMed ID: 27260206 [TBL] [Abstract][Full Text] [Related]
12. Requirement of IFN-gamma-mediated indoleamine 2,3-dioxygenase expression in the modulation of lymphocyte proliferation by human adipose-derived stem cells. DelaRosa O; Lombardo E; Beraza A; Mancheño-Corvo P; Ramirez C; Menta R; Rico L; Camarillo E; García L; Abad JL; Trigueros C; Delgado M; Büscher D Tissue Eng Part A; 2009 Oct; 15(10):2795-806. PubMed ID: 19231921 [TBL] [Abstract][Full Text] [Related]
13. Ex vivo immunosuppressive effects of mesenchymal stem cells on Crohn's disease mucosal T cells are largely dependent on indoleamine 2,3-dioxygenase activity and cell-cell contact. Ciccocioppo R; Cangemi GC; Kruzliak P; Gallia A; Betti E; Badulli C; Martinetti M; Cervio M; Pecci A; Bozzi V; Dionigi P; Visai L; Gurrado A; Alvisi C; Picone C; Monti M; Bernardo ME; Gobbi P; Corazza GR Stem Cell Res Ther; 2015 Jul; 6(1):137. PubMed ID: 26206376 [TBL] [Abstract][Full Text] [Related]
14. Human graft-derived mesenchymal stromal cells potently suppress alloreactive T-cell responses. de Mare-Bredemeijer EL; Mancham S; Verstegen MM; de Ruiter PE; van Gent R; O'Neill D; Tilanus HW; Metselaar HJ; de Jonge J; Kwekkeboom J; Hall SR; van der Laan LJ Stem Cells Dev; 2015 Jun; 24(12):1436-47. PubMed ID: 25744002 [TBL] [Abstract][Full Text] [Related]
15. [Mesenchymal stem cells and their immunological properties]. Lisianyĭ MI Fiziol Zh (1994); 2013; 59(3):126-34. PubMed ID: 23957174 [TBL] [Abstract][Full Text] [Related]
16. Bone marrow-derived mesenchymal stem cells favor the immunosuppressive T cells skewing in a Helicobacter pylori model of gastric cancer. Lin R; Ma H; Ding Z; Shi W; Qian W; Song J; Hou X Stem Cells Dev; 2013 Nov; 22(21):2836-48. PubMed ID: 23777268 [TBL] [Abstract][Full Text] [Related]
17. Immunoregulatory Effects of Mesenchymal Stem Cell-Derived Extracellular Vesicles on T Lymphocytes. Del Fattore A; Luciano R; Pascucci L; Goffredo BM; Giorda E; Scapaticci M; Fierabracci A; Muraca M Cell Transplant; 2015; 24(12):2615-27. PubMed ID: 25695896 [TBL] [Abstract][Full Text] [Related]
18. Cryopreserved mesenchymal stromal cells display impaired immunosuppressive properties as a result of heat-shock response and impaired interferon-γ licensing. François M; Copland IB; Yuan S; Romieu-Mourez R; Waller EK; Galipeau J Cytotherapy; 2012 Feb; 14(2):147-52. PubMed ID: 22029655 [TBL] [Abstract][Full Text] [Related]
19. Canine placenta: A promising potential source of highly proliferative and immunomodulatory mesenchymal stromal cells? Saulnier N; Loriau J; Febre M; Robert C; Rakic R; Bonte T; Buff S; Maddens S Vet Immunol Immunopathol; 2016 Mar; 171():47-55. PubMed ID: 26964717 [TBL] [Abstract][Full Text] [Related]
20. Human embryonic stem cell derived-mesenchymal stem cells: an alternative mesenchymal stem cell source for regenerative medicine therapy. Gadkari R; Zhao L; Teklemariam T; Hantash BM Regen Med; 2014; 9(4):453-65. PubMed ID: 25159063 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]